4.5 Editorial Material

Allogeneic hematopoietic cell transplantation versus drugs in myelofibrosis: the risk-benefit balancing act

Journal

BONE MARROW TRANSPLANTATION
Volume 45, Issue 3, Pages 419-421

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/bmt.2009.193

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available